Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies

/PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Nona Biosciences ,Jingsong Wang ,Prnewswire Nona Biosciences ,Linkedin ,Nasdaq ,Astrazeneca ,Senior Vice President ,Tumour Targeted Delivery ,